Literature DB >> 30470297

Urate-Lowering Therapy for Preventing Kidney Disease Progression: Are We There Yet?

Anushree Tiku1, Sunil V Badve2, David W Johnson3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30470297     DOI： 10.1053/j.ajkd.2018.07.022

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  4 in total

1.  Effect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes: A Systematic Review and Meta-Analysis.

Authors:  Qi Chen; Zi Wang; Jingwei Zhou; Zhenjie Chen; Yan Li; Shichao Li; Hukang Zhao; Sunil V Badve; Jicheng Lv
Journal:  Clin J Am Soc Nephrol       Date:  2020-10-14       Impact factor: 8.237

Review 2.  The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.

Authors:  Yuka Sato; Daniel I Feig; Austin G Stack; Duk-Hee Kang; Miguel A Lanaspa; A Ahsan Ejaz; L Gabriela Sánchez-Lozada; Masanari Kuwabara; Claudio Borghi; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2019-07-11       Impact factor: 28.314

3.  Minor Glomerular Abnormalities are Associated with Deterioration of Long-Term Kidney Function and Mitochondrial Injury.

Authors:  Byung Chul Yu; Nam-Jun Cho; Samel Park; Hyoungnae Kim; Hyo-Wook Gil; Eun Young Lee; Soon Hyo Kwon; Jin Seok Jeon; Hyunjin Noh; Dong Cheol Han; Ahrim Moon; Su Jung Park; Jin Kuk Kim; Seung Duk Hwang; Soo Jeong Choi; Moo Yong Park
Journal:  J Clin Med       Date:  2019-12-22       Impact factor: 4.241

4.  Effects of losartan and enalapril on serum uric acid and GFR in children with proteinuria.

Authors:  Charlotte E Bryant; Azita Rajai; Nicholas J A Webb; Ronald J Hogg
Journal:  Pediatr Nephrol       Date:  2021-04-21       Impact factor: 3.714
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.